Hanmi Pharm Co Ltd Capital Reinvestment Ratio
Hanmi Pharm Co Ltd capital reinvestment ratio. Hanmi Pharm Co Ltd (128940) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩42.02 Billion) in capital expenditures (₩15.95 Billion). See how much free cash does Hanmi Pharm Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hanmi Pharm Co Ltd (2010–2024)
Capital reinvestment ratio of Hanmi Pharm Co Ltd from 2010 to 2024. This chart tracks Hanmi Pharm Co Ltd's Capital Reinvestment Ratio across 13 annual periods. See financial flexibility index of Hanmi Pharm Co Ltd to measure the company's free cash flow as a share of total liabilities.
Hanmi Pharm Co Ltd Capital Reinvestment Ratio by Year (2010–2024)
Hanmi Pharm Co Ltd capital reinvestment ratio by year from 2010 to 2024. For the full cash flow conversion analysis, see Hanmi Pharm Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | ₩193.49 Billion | ₩62.55 Billion | ▲ +60.1% |
| 2023 | 0.20x | ₩216.54 Billion | ₩43.74 Billion | ▲ +7.9% |
| 2022 | 0.19x | ₩162.27 Billion | ₩30.38 Billion | ▲ +89.5% |
| 2021 | 0.10x | ₩201.92 Billion | ₩19.95 Billion | ▼ -64.2% |
| 2020 | 0.28x | ₩151.53 Billion | ₩41.82 Billion | ▼ -97.9% |
| 2019 | 13.35x | ₩12.45 Billion | ₩166.13 Billion | ▲ +90.3% |
| 2018 | 7.02x | ₩25.98 Billion | ₩182.27 Billion | ▲ +1192.8% |
| 2016 | 0.54x | ₩412.97 Billion | ₩224.09 Billion | ▼ -54.4% |
| 2015 | 1.19x | ₩101.71 Billion | ₩121.07 Billion | ▲ +285.2% |
| 2013 | 0.31x | ₩85.99 Billion | ₩26.57 Billion | ▲ +40.9% |
| 2012 | 0.22x | ₩63.27 Billion | ₩13.87 Billion | ▼ -31.3% |
| 2011 | 0.32x | ₩61.30 Billion | ₩19.56 Billion | ▼ -70.5% |
| 2010 | 1.08x | ₩18.94 Billion | ₩20.46 Billion | — |